[{"id":"f74c33fb-8184-4308-8fa0-35601fb0704d","acronym":"","url":"https://clinicaltrials.gov/study/NCT05741359","created_at":"2023-02-23T15:01:14.380Z","updated_at":"2024-07-02T16:35:24.228Z","phase":"Phase 1","brief_title":"The Safety and Efficacy of BRL-201 in the Treatment of r/r B Lymphocyte Non-Hodgkin Lymphoma","source_id_and_acronym":"NCT05741359","lead_sponsor":"Bioray Laboratories","biomarkers":" CD19","pipe":" | ","alterations":" CD19 expression","tags":["CD19"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BRL-201"],"overall_status":"Recruiting","enrollment":" Enrollment 18","initiation":"Initiation: 04/25/2023","start_date":" 04/25/2023","primary_txt":" Primary completion: 01/20/2024","primary_completion_date":" 01/20/2024","study_txt":" Completion: 03/15/2024","study_completion_date":" 03/15/2024","last_update_posted":"2024-01-08"}]